Filing Details

Accession Number:
0001181431-14-027050
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-07-18 17:11:17
Reporting Period:
2014-07-16
Filing Date:
2014-07-18
Accepted Time:
2014-07-18 17:11:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1454983 S Richard Levy Experimental Station
Route 141 And Henry Clay Rd
Wilmington DE 19880
Evp, Chief Drug Dev&Medical Of No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-07-16 8,000 $14.72 12,301 No 4 M Direct
Common Stock Disposition 2014-07-16 8,000 $48.15 4,301 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-07-16 8,000 $0.00 8,000 $14.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
68,317 2018-01-24 No 4 M Direct
Footnotes
  1. Beginning January 25, 2011, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
  2. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  3. Represents weighted average sale price. Actual sales prices ranged from $47.48 - $48.77.
  4. Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares.